Insider Trading June 23, 2026 05:16 PM

Qualys Legal Officer Executes Pre-Arranged Share Sale Amidst Recent Stock Volatility

Bruce Posey disposes of 865 shares valued at $94,668 under a Rule 10b5-1 plan, as the cybersecurity firm navigates mixed analyst sentiment following strong Q1 earnings.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
QLYS

Bruce K. Posey, the Chief Legal Officer at Qualys, Inc. (NASDAQ:QLYS), executed a sale of company shares totaling $94,668 on June 22, 2026. The transaction involved the disposition of 865 shares traded at prices between $107.17 and $112.145, conducted under a Rule 10b5-1 trading plan established on August 21, 2025. Following this sale, Posey retains direct ownership of 64,571 shares. This insider activity occurs as Qualys stock trades at $112.28, reflecting a 23% decline over the past year, despite underlying financial strength indicators suggesting undervaluation and robust health metrics.

Qualys Legal Officer Executes Pre-Arranged Share Sale Amidst Recent Stock Volatility
QLYS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Bruce Posey sold 865 shares valued at $94,668 under a Rule 10b5-1 plan, leaving him with 64,571 shares.
  • Qualys reported Q1 2026 earnings of $1.95 per share and revenue of $175.64 million, beating analyst estimates.
  • Analyst targets diverge, with Scotiabank lowering its target to $100 and RBC Capital raising its to $90, both maintaining Sector Perform ratings.

On June 22, 2026, Bruce K. Posey, serving as the Chief Legal Officer for Qualys, Inc. (NASDAQ:QLYS), finalized a transaction involving the sale of company equity. The total value of the shares disposed of was recorded at $94,668. This disposition comprised exactly 865 shares of Qualys common stock, which were sold at varying price points within a range of $107.17 to $112.145 per share. The execution of these sales was governed by a Rule 10b5-1 trading plan, a mechanism designed to facilitate the purchase or sale of securities in a way that avoids allegations of insider trading. Mr. Posey originally adopted this specific trading plan on August 21, 2025.

Following the completion of these transactions, Mr. Posey’s direct holding in Qualys common stock stands at 64,571 shares. The timing of this insider sale coincides with a period of price adjustment for the cybersecurity firm's equity. Qualys stock is currently trading at $112.28, a figure that reflects a 23% decline over the past year. Despite this recent downward trajectory, analytical assessments indicate that the stock may remain undervalued relative to its calculated Fair Value. Furthermore, the company maintains a financial health score of 3.1, categorized as "GREAT." Operational metrics further support this assessment, with the cybersecurity firm reporting an impressive gross profit margin of 83% and holding a balance sheet where cash positions exceed debt obligations.

Recent corporate developments provide additional context to the current market environment for Qualys. The company reported its first-quarter 2026 earnings results, which surpassed analyst expectations. The reported earnings per share reached $1.95, exceeding the forecasted $1.80. Revenue figures also outpaced projections, totaling $175.64 million against an anticipated $173.68 million. In a significant operational milestone, Qualys announced that its TotalCloud solution has achieved FedRAMP High Authorization, sponsored by the U.S. Drug Enforcement Agency. This authorization expands the FedRAMP High status of the Qualys Government Platform to encompass the Cloud-Native Application Protection Platform.

Analyst sentiment regarding the stock presents a mixed outlook. Scotiabank recently lowered its price target for Qualys shares from $135 to $100, while maintaining a Sector Perform rating. The firm cited an 8% growth in current billings for the first quarter as a key factor in its reassessment. Conversely, RBC Capital raised its price target on Qualys from $85 to $90, also maintaining a Sector Perform rating. RBC highlighted solid business momentum and positive feedback regarding specific products such as QFlex. Market data indicates the stock closed at 112.28, up 3.77 or 3.47%, with after-hours trading showing a further increase to 114.47, up 2.14 or 1.90%.

Risks

  • The stock has declined 23% over the past year, indicating potential market volatility or valuation concerns despite strong fundamentals.
  • Divergent analyst price targets reflect uncertainty in the near-term valuation trajectory for the cybersecurity sector.
  • Regulatory compliance requirements for FedRAMP High Authorization impose ongoing operational and reporting obligations.

More from Insider Trading

Navan Leadership Transaction and Strategic Expansion Analysis Jun 23, 2026 Navan CTO Executes RSU-Related Sale Amid Strategic Expansion Jun 23, 2026 Navan Executive Executes Mandatory Share Sale Amid Strong Q1 Growth Jun 23, 2026 Espey Manufacturing CHRO Jennifer Pickering Executes Stock Transactions Amid Dividend Declaration Jun 23, 2026 Guardant Health Director Tariq Musa Divests $255,893 in Shares Amid Valuation Questions Jun 23, 2026